Personalized Circulating Tumor DNA Profiling Enables Superior and…
A blood test that detects cancer DNA fragments predicts which leukemia patients will relapse far better than current methods, potentially sparing some from unnecessary treatment.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Deep Learning Enables Automated Detection of Mature B Cell Neoplasms…
Artificial intelligence now spots blood cancers in flow cytometry tests with 97.5% accuracy, helping pathologists work faster and more reliably.
Promising but preliminaryKMT2A-Partial Tandem Duplication Associates With Leukemia…
Identifying a specific genetic change in bone marrow cells lets doctors spot which myelodysplastic syndrome patients are heading toward leukemia, so they can intervene earlier.
Promising but preliminaryGlofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma
A new antibody drug achieves remission in most patients with relapsed brain lymphomas, with mostly mild side effects that doctors can manage.
Promising but preliminaryKDM4C inhibition reinforces NK cell cytotoxicity through the…
Blocking a specific protein makes aggressive leukemia cells self-destruct and become invisible to immune cells, while simultaneously awakening those immune cells to attack more aggressively.